These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 24229503

  • 1. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y.
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [Abstract] [Full Text] [Related]

  • 2. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
    Shirasaka T, Miyagawa S, Fukushima S, Saito A, Shiozaki M, Kawaguchi N, Matsuura N, Nakatani S, Sakai Y, Daimon T, Okita Y, Sawa Y.
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
    [Abstract] [Full Text] [Related]

  • 3. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.
    Kondoh H, Sawa Y, Miyagawa S, Sakakida-Kitagawa S, Memon IA, Kawaguchi N, Matsuura N, Shimizu T, Okano T, Matsuda H.
    Cardiovasc Res; 2006 Feb 01; 69(2):466-75. PubMed ID: 16423569
    [Abstract] [Full Text] [Related]

  • 4. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y, Soeki T, Akaike M, Sakai Y, Igarashi T, Sata M.
    Biomed Pharmacother; 2009 Dec 01; 63(10):781-6. PubMed ID: 19906506
    [Abstract] [Full Text] [Related]

  • 5. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A, Prudhon B, Salmon A, Doyennette MA, Fiszman MY, Fromes Y.
    Basic Res Cardiol; 2005 Mar 01; 100(2):161-70. PubMed ID: 15611844
    [Abstract] [Full Text] [Related]

  • 6. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL.
    J Thorac Cardiovasc Surg; 2005 Aug 01; 130(2):321-9. PubMed ID: 16077394
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH, He JG, Wu JL, Yang L, Zhang DS, Tan XY, Qi RD.
    Cytotherapy; 2008 Aug 01; 10(8):857-67. PubMed ID: 18956268
    [Abstract] [Full Text] [Related]

  • 8. Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model.
    Kubota Y, Miyagawa S, Fukushima S, Saito A, Watabe H, Daimon T, Sakai Y, Akita T, Sawa Y.
    J Thorac Cardiovasc Surg; 2014 Mar 01; 147(3):1081-7. PubMed ID: 24131787
    [Abstract] [Full Text] [Related]

  • 9. The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster.
    Kido T, Miyagawa S, Goto T, Tamai K, Ueno T, Toda K, Kuratani T, Sawa Y.
    PLoS One; 2018 Mar 01; 13(12):e0202838. PubMed ID: 30517097
    [Abstract] [Full Text] [Related]

  • 10. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
    Nakamura K, Sata M, Iwata H, Sakai Y, Hirata Y, Kugiyama K, Nagai R.
    Clin Sci (Lond); 2007 Jun 01; 112(12):607-16. PubMed ID: 17263691
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes.
    Saygili E, Noor-Ebad F, Schröder JW, Mischke K, Saygili E, Rackauskas G, Marx N, Kelm M, Rana OR.
    Biochem Biophys Res Commun; 2015 Sep 11; 465(1):119-24. PubMed ID: 26248134
    [Abstract] [Full Text] [Related]

  • 12. Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy.
    Kondoh H, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Kitagawa-Sakakida S, Memon IA, Kawaguchi N, Matsuura N, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Aug 11; 130(2):295-302. PubMed ID: 16077390
    [Abstract] [Full Text] [Related]

  • 13. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.
    Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C, Li Z.
    Stem Cell Res Ther; 2017 Jan 28; 8(1):18. PubMed ID: 28129792
    [Abstract] [Full Text] [Related]

  • 14. New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy.
    Roura S, Gálvez-Montón C, Pujal JM, Casani L, Fernández MA, Astier L, Gastelurrutia P, Domingo M, Prat-Vidal C, Soler-Botija C, Llucià-Valldeperas A, Llorente-Cortés V, Bayes-Genis A.
    Atherosclerosis; 2013 Oct 28; 230(2):354-64. PubMed ID: 24075768
    [Abstract] [Full Text] [Related]

  • 15. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S.
    Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640
    [Abstract] [Full Text] [Related]

  • 16. Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy.
    Mizuno Y, Uchinaka A, Horii Y, Mori S, Hamada Y, Miyagawa S, Saito A, Sawa Y, Matsuura N, Kawaguchi N.
    Interact Cardiovasc Thorac Surg; 2015 Oct 30; 21(4):506-14. PubMed ID: 26188018
    [Abstract] [Full Text] [Related]

  • 17. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia.
    Luo JY, Wu GF, Xiong Y, Chen GW, Xie Q, Yang DY, He XH, Zhang Y, Liu DH, Wang KJ, Ma H, Zheng ZS, DU ZM.
    Chin Med J (Engl); 2009 May 20; 122(10):1188-94. PubMed ID: 19493469
    [Abstract] [Full Text] [Related]

  • 18. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
    Mewhort HE, Turnbull JD, Meijndert HC, Ngu JM, Fedak PW.
    J Thorac Cardiovasc Surg; 2014 May 20; 147(5):1650-9. PubMed ID: 24075463
    [Abstract] [Full Text] [Related]

  • 19. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
    Muranaka H, Marui A, Tsukashita M, Wang J, Nakano J, Ikeda T, Sakata R.
    J Thorac Cardiovasc Surg; 2010 Oct 20; 140(4):916-22. PubMed ID: 20381089
    [Abstract] [Full Text] [Related]

  • 20. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
    Guo Y, Liu C, He J.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun 20; 25(6):736-40. PubMed ID: 21735790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.